Berry Genomics released its performance for the first three quarters, with a net loss attributable to the parent company of 52.5637 million yuan
According to the Zhitong Finance APP, Berry Genomics released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 686 million yuan, a year-on-year decrease of 16.65%. The net loss attributable to shareholders of the listed company was 52.5637 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 53.7914 million yuan
According to the Zhitong Finance APP, Berry Genomics (000710.SZ) released its third-quarter report for 2025. In the first three quarters, the company achieved operating revenue of 686 million yuan, a year-on-year decrease of 16.65%. The net loss attributable to shareholders of the listed company was 52.5637 million yuan. The net loss attributable to shareholders of the listed company, excluding non-recurring gains and losses, was 53.7914 million yuan
